AbCellera Biologics Inc. (ABCL) Operating cash flow 2019–2025
AbCellera Biologics Inc. (ABCL) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$131.3MFY2025 · since FY2019: $2.7M → -$131.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$131.3M | -20.9% |
| FY2024 | -$108.6M | -147.4% |
| FY2023 | -$43.9M | -115.8% |
| FY2022 | $277.4M | +13.4% |
| FY2021 | $244.6M | +977.9% |
| FY2020 | $22.7M | +742.2% |
| FY2019 | $2.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice